Emerging strategies for cancer therapy by ATR inhibitors
Cancer Science · 2023-07 · 114 (7) · 2709-2721
DOI: 10.1111/cas.15845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 15.05.2023. Verfasst von Kimiyoshi Yano und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Stress Signaling, National Cancer Center Research Institute, Tokyo, Japan. Hauptthemen laut MEDLINE: DNA Damage, Neoplasms. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
DNA replication stress (RS) causes genomic instability and vulnerability in cancer cells. To counteract RS, cells have evolved various mechanisms involving the ATR kinase signaling pathway, which regulates origin firing, cell cycle checkpoints, and fork stabilization to secure the fidelity of replication. However, ATR signaling also alleviates RS to support cell survival by driving RS tolerance, thereby contributing to therapeutic resistance. Cancer cells harboring genetic mutations and other changes that disrupt normal DNA replication increase the risk of DNA damage and the levels of RS, conferring addiction to ATR activity for sustainable replication and susceptibility to therapeutic approaches using ATR inhibitors (ATRis). Therefore, clinical trials are currently being conducted to evaluate the efficacy of ATRis as monotherapies or in combination with other drugs and biomarkers. In this review, we discuss recent advances in the elucidation of the mechanisms by which ATR functions in the RS response and its therapeutic relevance when utilizing ATRis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Stress Signaling, National Cancer Center Research Institute, Tokyo, Japan.
ORCID-Profile: Bunsyo Shiotani
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yano, K., & Shiotani, B. (2023). Emerging strategies for cancer therapy by ATR inhibitors. Cancer Science, 114(7), 2709-2721. https://doi.org/10.1111/cas.15845
Vancouver
Yano K, Shiotani B. Emerging strategies for cancer therapy by ATR inhibitors. Cancer Science. 2023;114(7):2709-2721. doi:10.1111/cas.15845
BibTeX
@article{Yano2023,
author = {Yano, Kimiyoshi and Shiotani, Bunsyo},
title = {Emerging strategies for cancer therapy by ATR inhibitors},
journal = {Cancer Science},
year = {2023},
volume = {114},
number = {7},
pages = {2709--2721},
doi = {10.1111/cas.15845}
}
EUVIMED